20 studies found for:    cantos
Show Display Options
Rank Status Study
1 Recruiting Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
Condition: Atherosclerosis
Interventions: Drug: Canakinumab;   Drug: Placebo
2 Recruiting Breast Cancer Toxicity
Condition: Non-metastatic Breast Cancer
Intervention: Procedure: blood sampling
3 Active, not recruiting Interleukin-1 Blockade With Canakinumab to Improve Exercise Capacity in Patients With Chronic Systolic Heart Failure and Elevated Hs-CRP
Conditions: Prior Acute Myocardial Infarction;   Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l);   Reduced Left Ventricle Ejection Fraction (<50%);   Symptoms of Heart Failure (NYHA Class II-III)
Interventions: Other: Cardiopulmonary exercise test;   Other: Echocardiogram
4 Recruiting Predicting Risk of Cancer in Barrett's Esophagus
Conditions: Barrett Esophagus;   Esophageal Neoplasm;   Gastroesophageal Reflux
Intervention:
5 Recruiting Neurotoxicity Characterization Study of Nab-paclitaxel Versus Conventional Paclitaxel in Metastatic Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Paclitaxel 80 mg/m2;   Drug: Nab-paclitaxel 100 mg/m2 days 1, 8 and 15;   Drug: Nab-paclitaxel 150 mg/m2 days 1, 8 and 15;   Drug: Nab-paclitaxel 150 mg/m2 days 1 and 15
6 Recruiting Familial Barrett's Esophagus
Conditions: Barrett's Esophagus;   Esophageal Neoplasm
Intervention:
7 Unknown  Autologous Stem Cells Derived From Lipoaspirates for the Non-Surgical Treatment of Complex Perianal Fistula
Condition: Anal Fistula
Intervention: Procedure: Non-surgical autologous implant of ASCs
8 Completed Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For Epilepsy
Condition: Epilepsy
Interventions: Drug: lamotrigine;   Drug: valproic acid
9 Recruiting Screening for Early Pancreatic Neoplasia (Cancer of the Pancreas Screening or CAPS4 Study)
Conditions: Early Pancreatic Neoplasia;   Familial Pancreatic Neoplasia
Intervention:
10 Recruiting The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Condition: Colorectal Cancer
Interventions: Drug: Methylene Blue MMX®;   Drug: Placebo
11 Recruiting Adolescent Master Protocol for Participants 18 Years of Age and Older (AMP Up)
Condition: HIV/AIDS
Intervention:
12 Recruiting Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women
Condition: Antiretroviral Toxicity
Intervention:
13 Completed Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
Condition: Barrett's Esophagus, Esophageal Intraepithelial Neoplasia
Intervention: Procedure: endomicroscopy
14 Enrolling by invitation Ism1 Versus EmbryoGen Media for Embryo Culture in Previous Pregnancy Loss Cases
Conditions: Infertility;   Miscarriage
Intervention:
15 Enrolling by invitation ISM1 Versus EmbrioGen Media for Embryo Culture With Previous Failure Implantation in ART Treatments
Conditions: Infertility;   Implantation Failure
Intervention:
16 Completed
Has Results
Confocal Endomicroscopy for Barrett's Esophagus
Conditions: Barrett's Esophagus;   Esophageal Adenocarcinoma
Interventions: Device: confocal laser endomicroscopy (CLE);   Device: standard endoscopy (EGD)
17 Completed Cancer of the Pancreas Screening Study (CAPS 3)
Conditions: Pancreatic Neoplasm;   Peutz-Jeghers Syndrome
Interventions: Procedure: Biopsy, Fine Needle Aspiration (FNA);   Drug: Secretin (human synthetic) - ChiRhoClin
18 Recruiting A Randomized Study of TH Versus THL in First Line Treatment of HER2-positive Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab;   Drug: Paclitaxel;   Drug: Lapatinib
19 Recruiting A Phase 2 of GS-9973 in Subjects With Relapsed or Refractory Hematologic Malignancies
Conditions: Chronic Lymphocytic Leukemia;   Mantle Cell Lymphoma;   Diffuse Large B-cell Lymphoma;   Non-FL Indolent Non-Hodgkin's Lymphoma;   Follicular Lymphoma
Interventions: Drug: GS-9973;   Drug: GS-9973 SDD
20 Recruiting Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Barrett's Epithelium
Condition: Barrett's Esophagus
Interventions: Device: Cryoballoon Focal Ablation System - 6 seconds;   Device: Cryoballoon Focal Ablation System - 8 seconds

Indicates status has not been verified in more than two years